THOMAS KOSTEN to Amphetamine-Related Disorders
This is a "connection" page, showing publications THOMAS KOSTEN has written about Amphetamine-Related Disorders.
Connection Strength
2.081
-
Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant. Am J Addict. 2019 02; 28(2):119-126.
Score: 0.588
-
Epidemiological trends and the advances of treatments of amphetamine-type stimulants (ATS) in China. Am J Addict. 2014 May-Jun; 23(3):313-7.
Score: 0.423
-
Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2014 Feb; 77(2):368-74.
Score: 0.416
-
Current concepts in pharmacotherapy of substance abuse. Curr Psychiatry Rep. 1999 Dec; 1(2):172-8.
Score: 0.156
-
Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine. Am J Addict. 2015 Dec; 24(8):748-55.
Score: 0.118
-
Gender differences in socio-demographic and clinical characteristics of methamphetamine inpatients in a Chinese population. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):94-100.
Score: 0.096
-
A vaccine against methamphetamine attenuates its behavioral effects in mice. Drug Alcohol Depend. 2013 Apr 01; 129(1-2):41-8.
Score: 0.095
-
Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am J Drug Alcohol Abuse. 2009; 35(3):161-77.
Score: 0.073
-
Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches. Am J Drug Alcohol Abuse. 2007; 33(6):765-7.
Score: 0.064
-
Therapeutic vaccines for substance dependence. Expert Rev Vaccines. 2004 Feb; 3(1):11-8.
Score: 0.052